Michel Eichelbaum - Concepedia

Author

Michel Eichelbaum

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology ORCID

Also Known As

G J Meyer, M EICHELBAUM, M Eichelbaum, M. EICHELBAUM, M. Eichelbaum, M.F. Eichelbaum, Malte Eichelbaum, Michel EICHELBAUM, Michel Eichelbaum, Michel F Eichelbaum

432

Publications

33.4K

Citations

100

H-Index

209

Concepts

All Affiliations

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology University of Tübingen University of Bonn Robert Bosch (Germany)Robert Bosch Hospital

About

Michel Eichelbaum is an author at Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	54	126	10.7K
2	Health Sciences	15	15	2.1K
3	Engineering	3	3	94
4	Education	1	1	33
5	Language Studies	1	1	18

Michel Eichelbaum

252

Publications

27.9K

Citations

H-Index

Page 1

	Year	Citations
Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity <i>in</i> <i>vivo</i> Sven Hoffmeyer, Oliver Burk, Oliver von Richter, Proceedings of the National Academy of Sciences	2000	2.4K
The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin Bernd Greiner, Michel Eichelbaum, Péter Fritz, Journal of Clinical Investigation	1999	916
Nuclear Receptor Response Elements Mediate Induction of Intestinal MDR1 by Rifampin Anke Geick, Michel Eichelbaum, Oliver Burk Journal of Biological Chemistry	2001	840
Defective N-oxidation of sparteine in man: A new pharmacogenetic defect Michel Eichelbaum, N. Spannbrucker, Barbara Steincke, European Journal of Clinical Pharmacology Defective N-oxidationBiochemistryMedicinePhysiologyMetabolism	1979	635
Sex Is A Major Determinant of Cyp3a4 Expression in Human Liver Renzo Wolbold, Kathrin Klein, Oliver Burk, Hepatology Systems BiologyHepatologyCyp3a4 ExpressionLiver PhysiologyGenetics	2003	495
Breast Cancer Treatment Outcome With Adjuvant Tamoxifen Relative to Patient CYP2D6 and CYP2C19 Genotypes Werner Schroth, Lydia Antoniadou, Péter Fritz, Journal of Clinical Oncology	2007	465
Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury Is Influenced by Multiple HLA Class I and II Alleles M. Isabel Lucena, Mariam Molokhia, Yufeng Shen, Gastroenterology InflammationHepatologyMultiple Hla ClassHealth SciencesMedicine	2011	463
Comprehensive analysis of thiopurine S-methyltransferase phenotype–genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants Elke Schaeffeler, Christine Fischer, D. Brockmeier, Pharmacogenetics GeneticsGenetic EpidemiologyHuman PolymorphismPathologyLarge Population	2004	417
High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1) Mikko Niemi, Elke Schaeffeler, Thomas Lang, Pharmacogenetics	2004	416
Nomenclature for human CYP2D6 alleles Ann K. Daly, Jürgen Brockmöller, Franck Broly, Pharmacogenetics BiologyGenetic AnalysisAllelic VariantSeparate AlleleGenetic Disorder	1996	399

Page 1